Closed
Evaluation of Cancer Strategy for Scotland
Scottish Government · £180,000 · closes 15 Feb 2024
£180,000
Estimated value
Closed
Deadline
11 Jan 2024
Published
This tender has closed.
See what's open in research and development, or get contracts like this in your inbox each morning — free.
About this contract
The Scottish Government has a requirement to place a contract with an external service provider for the provision of the Evaluation of Cancer Strategy for Scotland.
Key dates
Published11 Jan 2024
Submission deadline15 Feb 2024 Add to calendar ↓
Source
Source notice on Find a TenderView ↗
Lot — bid on it if it fits
This contract has one lot. Bid if it suits your firm.
The Scottish Government has a requirement to place a contract with an external service provider for the provision of the Evaluation of Cancer Strategy for Scotland.
Aligned to priorities highlighted in the Policy Prospectus and Care and Wellbeing Portfolio, this project seeks to provide evidence to understand the effects and impacts of cancer policy actions on people affected by cancer. The aim is to provide insights to evaluate who progresses smoothly (or not) along the pathway, in what way, and why, and what barriers (if any) are experienced. This will include evidence about how different elements or models of support work along the pathway, and how the pathway is experienced by different demographic groups, with a focus on those who have been underserved historically. In looking along the pathway, it will be important to focus on two initiatives that are being implemented in NHS Boards to support people affected by cancer along the pathway: Improving the Cancer Journey (Action 94, 2023-2036 Action Plan) and a Single Point of Contact (Action 95, 2023-2036 Action Plan). To support the ambition to tackle health inequalities, evidence should be gathered from individuals and groups who experience socio-economic inequalities, racism and discrimination, and in rural and island communities, where there are particular challenges in providing equity of access, as highlighted in the Cancer Strategy. Data will contribute evidence connected with high-level strategic outcomes of the Cancer Strategy: improved experience of services and optimised quality of life, which themselves contribute to the strategic aim to improve cancer survival and provide excellent, equitably accessible care.
The contract will be for a period of up to 24 months with the option to extend for an additional 3 months Additional information: Some question will have a minimum pass mark of 2 suppliers who do not meet the minimum score of 2 will not proceed to commercial evaluation.£180,000
Who to contact
Phone+44 7392287522
Similar open tenders
closes 17 Aug 2026
closes 18 Oct 2027
closes 6 Oct 2028
Contains public sector information licensed under OGL v3.0